Intellia Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

INTELLIA THERAPEUTICS

07/11/2024 15:11

* Intellia Therapeutics Inc  NTLA.OQ  reported a quarterly
adjusted loss of $1.34​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $-1.38.  The mean expectation of twenty
seven analysts for the quarter was for a loss of $1.38 per
share. Wall Street expected results to range from $-1.57
to $-1.06 per share.
    * Revenue fell 24% to $9.11 million from a year ago;
analysts
expected $7.86 million. 
    * Intellia Therapeutics Inc's reported EPS for the quarter
was a
loss of $1.34​.
    * The company reported a quarterly loss of $135.71 million.
    * Intellia Therapeutics Inc shares had fallen by 21.8% this
quarter and lost 47.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 23 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Intellia
Therapeutics Inc is 62.00 
This summary was machine generated from LSEG data November 7 at
03:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.38          -1.34          Beat
 Jun. 30 2024      -1.23          -1.52          Missed
 Mar. 31 2024      -1.38          -1.12          Beat
 Dec. 31 2023      -1.45          -1.46          Missed